Mirae Asset Global Investments Co., Ltd. Biomarin Pharmaceutical Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $20 Billion
  • Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,237 shares of BMRN stock, worth $514,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,237
Previous 108,081 93.3%
Holding current value
$514,840
Previous $9.44 Million 93.7%
% of portfolio
0.0%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$74.43 - $92.22 $7.51 Million - $9.3 Million
-100,844 Reduced 93.3%
7,237 $595,000
Q1 2024

May 01, 2024
BUY
$83.81 - $99.0 $4.76 Million - $5.62 Million
56,784 Added 110.7%
108,081 $9.44 Million
Q4 2023

Jan 24, 2024
SELL
$76.22 - $98.51 $3.89 Million - $5.02 Million
-50,979 Reduced 49.84%
51,297 $4.95 Million
Q3 2023

Oct 26, 2023
BUY
$85.07 - $94.48 $115,610 - $128,398
1,359 Added 1.35%
102,276 $9.05 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $8.74 Million - $10.1 Million
-100,848 Reduced 49.98%
100,917 $8.75 Million
Q1 2023

May 04, 2023
BUY
$87.74 - $117.27 $8.67 Million - $11.6 Million
98,818 Added 95.99%
201,765 $19.6 Million
Q4 2022

Feb 09, 2023
SELL
$80.93 - $108.63 $1.46 Million - $1.95 Million
-17,990 Reduced 14.88%
102,947 $10.7 Million
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $1.02 Million - $1.2 Million
12,409 Added 11.43%
120,937 $10.3 Million
Q2 2022

Jul 26, 2022
SELL
$71.48 - $86.85 $2.18 Million - $2.65 Million
-30,542 Reduced 21.96%
108,528 $8.99 Million
Q1 2022

May 10, 2022
SELL
$74.28 - $92.69 $1.8 Million - $2.24 Million
-24,177 Reduced 14.81%
139,070 $10.7 Million
Q4 2021

Feb 08, 2022
BUY
$71.72 - $91.47 $900,086 - $1.15 Million
12,550 Added 8.33%
163,247 $14.4 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $2.22 Million - $2.53 Million
29,653 Added 24.5%
150,697 $11.6 Million
Q2 2021

Aug 11, 2021
BUY
$75.51 - $84.79 $2.05 Million - $2.3 Million
27,156 Added 28.92%
121,044 $10.1 Million
Q1 2021

May 13, 2021
BUY
$74.73 - $90.69 $2.64 Million - $3.2 Million
35,280 Added 60.2%
93,888 $7.09 Million
Q4 2020

Feb 10, 2021
SELL
$72.61 - $90.2 $1.2 Million - $1.48 Million
-16,459 Reduced 21.93%
58,608 $5.14 Million
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $1.11 Million - $2.03 Million
15,502 Added 26.03%
75,067 $5.71 Million
Q2 2020

Aug 11, 2020
BUY
$79.55 - $124.22 $873,777 - $1.36 Million
10,984 Added 22.61%
59,565 $7.35 Million
Q1 2020

May 12, 2020
BUY
$71.37 - $96.85 $495,878 - $672,913
6,948 Added 16.69%
48,581 $4.11 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $508,568 - $683,445
7,913 Added 23.47%
41,633 $3.52 Million
Q3 2019

Nov 12, 2019
BUY
$67.4 - $85.11 $511,026 - $645,304
7,582 Added 29.01%
33,720 $2.27 Million
Q2 2019

Aug 13, 2019
BUY
$80.35 - $93.9 $338,755 - $395,882
4,216 Added 19.23%
26,138 $2.23 Million
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $176,651 - $206,904
2,098 Added 10.58%
21,922 $1.94 Million
Q4 2018

Feb 11, 2019
BUY
$80.14 - $106.07 $220,625 - $292,010
2,753 Added 16.13%
19,824 $1.69 Million
Q3 2018

Nov 13, 2018
BUY
$93.92 - $105.72 $322,239 - $362,725
3,431 Added 25.15%
17,071 $1.66 Million
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $145,787 - $189,939
1,918 Added 16.36%
13,640 $1.27 Million
Q1 2018

May 10, 2018
BUY
$77.67 - $92.63 $26,485 - $31,586
341 Added 3.0%
11,722 $951,000
Q4 2017

Feb 12, 2018
BUY
$80.76 - $95.13 $83,182 - $97,983
1,030 Added 9.95%
11,381 $1.02 Million
Q3 2017

Nov 08, 2017
BUY
$80.6 - $94.95 $185,380 - $218,385
2,300 Added 28.57%
10,351 $963,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,051
8,051 $727,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email